Francesca Patella
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Francesca Patella has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Filippo Pesapane
Breast Imaging Division, IEO European Institute of Oncology IRCCS, Milan, Italy
4 shared publications Gianpaolo Carrafiello
Postgraduate School of Radiodiagnostics, University of Milan, Milan, Italy
4 shared publicationsGiuseppe Franceschelli
Diagnostic & Interventional Radiology Service, San Paolo Hospital, Milan,Italy
4 shared publicationsAnna Maria Ierardi
Diagnostic & Interventional Radiology Service, San Paolo Hospital, Milan, Italy
3 shared publicationsEnrico Fumarola
Postgraduate School of Radiodiagnostics, University of Milan, Milan, Italy
2 shared publicationsFederico Biglioli
Maxillofacial Surgery Unit, ASST Santi Paolo e Carlo, Università degli Studi di Milano, Milan,Italy
2 shared publications
Latest Publications
- 6 April 2020
- Published by Taylor & Francis in Future Oncology
- Vol. 16 (12) , 763-778
Quantification of Heterogeneity to Classify Benign Parotid Tumors: A Feasibility Study on Most Frequent Histotypes
Aim: To differentiate Warthin tumors (WTs) and pleomorphic adenomas (PAs) measuring heterogeneity of intravoxel incoherent motion (IVIM) and dynamic-contrast enhanced-magnetic resonance imaging bio...
- 6 April 2020
- Published by Taylor & Francis in Future Oncology
- Vol. 16 (12) , 763-778
Quantification of Heterogeneity to Classify Benign Parotid Tumors: A Feasibility Study on Most Frequent Histotypes
Aim: To differentiate Warthin tumors (WTs) and pleomorphic adenomas (PAs) measuring heterogeneity of intravoxel incoherent motion (IVIM) and dynamic-contrast enhanced-magnetic resonance imaging bio...
- 2 May 2019
- Published by Taylor & Francis in Future Oncology
- Vol. 15 (15) , 1791-1804
Assessment of The Response of Hepatocellular Carcinoma To Interventional Radiology Treatments
According to Barcelona Clinic Liver Cancer (BCLC) guidelines, interventional radiology procedures are valuable treatment options for many hepatocellular carcinomas (HCCs) that are not amenable to r...
- 2 May 2019
- Published by Taylor & Francis in Future Oncology
- Vol. 15 (15) , 1791-1804
Assessment of The Response of Hepatocellular Carcinoma To Interventional Radiology Treatments
According to Barcelona Clinic Liver Cancer (BCLC) guidelines, interventional radiology procedures are valuable treatment options for many hepatocellular carcinomas (HCCs) that are not amenable to r...
- 1 December 2018
- Published by Taylor & Francis in Future Oncology
- Vol. 14 (28) , 2893-2903
A multiparametric analysis combining DCE-MRI- and IVIM -derived parameters to improve differentiation of parotid tumors: a pilot study
Aim: To evaluate dynamic contrast-enhanced (DCE)-MRI and diffusion weighted (DW)-MRI diagnostic value to differentiate Warthin tumors (WT) by pleomorphic adenomas (PA). Materials & methods: Seven WT and seven PA were examined. DCE- and DW-MRI parameters were extracted from volumes of interest; volume of interest-based averages and standard deviations were calculated. Statistical analysis included: linear discriminant analysis, receiver operating characteristic curves, sensitivity and specificity. Results: No single feature was able to differentiate WT by PA (p>0.05); linear discriminant analysis analysis showed that a combination of all features or combinations of feature pairs (namely: K-trans(std) & f(std), K-trans(std) & D(std), k(ep)(std) & D(std), MRE(av) & TTP(av)) might achieve sensitivity (SENS), specificity (SPEC) =100%, with a slight reduction after cross-validation analysis (SENS=0.875; SPEC=1). Conclusion: Although preliminary and not conclusive, our results suggest that differentiation between WT and PA is possible through a multiparametric approach based on combination of DCE- and DW-MRI parameters.
- 1 December 2018
- Published by Taylor & Francis in Future Oncology
- Vol. 14 (28) , 2893-2903
A multiparametric analysis combining DCE-MRI- and IVIM -derived parameters to improve differentiation of parotid tumors: a pilot study
Aim: To evaluate dynamic contrast-enhanced (DCE)-MRI and diffusion weighted (DW)-MRI diagnostic value to differentiate Warthin tumors (WT) by pleomorphic adenomas (PA). Materials & methods: Seven WT and seven PA were examined. DCE- and DW-MRI parameters were extracted from volumes of interest; volume of interest-based averages and standard deviations were calculated. Statistical analysis included: linear discriminant analysis, receiver operating characteristic curves, sensitivity and specificity. Results: No single feature was able to differentiate WT by PA (p>0.05); linear discriminant analysis analysis showed that a combination of all features or combinations of feature pairs (namely: K-trans(std) & f(std), K-trans(std) & D(std), k(ep)(std) & D(std), MRE(av) & TTP(av)) might achieve sensitivity (SENS), specificity (SPEC) =100%, with a slight reduction after cross-validation analysis (SENS=0.875; SPEC=1). Conclusion: Although preliminary and not conclusive, our results suggest that differentiation between WT and PA is possible through a multiparametric approach based on combination of DCE- and DW-MRI parameters.
- 10 July 2018
- Published by Taylor & Francis in Future Oncology
- Vol. 14 (28) , 2969-2984
DEB-TACE: A Standard Review
Drug-eluting bead transarterial chemoembolization (DEB-TACE) is a relative new endovascular treatment based on the use of microspheres to release chemotherapeutic agents within a target lesion with controlled pharmacokinetics. This aspect justifies the immediate success of DEB-TACE, that nowadays represents one of the most used treatments for unresectable hepatocellular carcinoma. However, there is no consensus about the choice of the best embolotherapy technique. In this review, we describe the available microspheres and report the results of the main comparative studies, to clarify the role of DEB-TACE in the hepatocellular carcinoma management. We underline that there is no evidence about the superiority of DEB-TACE over conventional TACE in terms of efficacy, but there may be some benefits with respect to safety especially with the improvement of new technologies.
- 10 July 2018
- Published by Taylor & Francis in Future Oncology
- Vol. 14 (28) , 2969-2984
DEB-TACE: A Standard Review
Drug-eluting bead transarterial chemoembolization (DEB-TACE) is a relative new endovascular treatment based on the use of microspheres to release chemotherapeutic agents within a target lesion with controlled pharmacokinetics. This aspect justifies the immediate success of DEB-TACE, that nowadays represents one of the most used treatments for unresectable hepatocellular carcinoma. However, there is no consensus about the choice of the best embolotherapy technique. In this review, we describe the available microspheres and report the results of the main comparative studies, to clarify the role of DEB-TACE in the hepatocellular carcinoma management. We underline that there is no evidence about the superiority of DEB-TACE over conventional TACE in terms of efficacy, but there may be some benefits with respect to safety especially with the improvement of new technologies.
- Open Access
- 1 April 2018
- Published by AME Publishing Company in Gland Surgery
- Vol. 7 (2) , 103-110
The role of interventional radiology in the treatment of epiphora
Epiphora is a relatively common ophthalmologic affection representing almost 5% of clinical consultations in ophthalmology and it consists in the complete or partial obstruction of nasolacrimal duct, leading to insufficient drainage of tears. The traditional treatment is represented by surgery namely, external dacryocystorhinostomy (DCR). Despite the high success rate DCR has many disadvantages and limitations since it requires general anesthesia, it may arise in a permanent facial scar and it is often affected by the reobstruction of the anastomotic tract by fibrotic scars and osteogenic activity. Fluoroscopically guided interventional procedures are a therapeutic alternative to surgery for lacrimal duct system obstructions that can consist either in balloon dacryocystoplasty or in nasolacrimal stent placement. In both cases, a pre-operative imaging characterization of the occlusion is needed for a correct treatment planning. In this review, we propose to highlight the role of interventional radiology in the treatment of epiphora and the role of computed tomography dacryocystography (CTD) in depiction and the pre-interventional planning.
- 1 April 2018
- Published by AME Publishing Company in Gland Surgery
- Vol. 7 (2) , 103-110
Open AccessThe role of interventional radiology in the treatment of epiphora
Epiphora is a relatively common ophthalmologic affection representing almost 5% of clinical consultations in ophthalmology and it consists in the complete or partial obstruction of nasolacrimal duct, leading to insufficient drainage of tears. The traditional treatment is represented by surgery namely, external dacryocystorhinostomy (DCR). Despite the high success rate DCR has many disadvantages and limitations since it requires general anesthesia, it may arise in a permanent facial scar and it is often affected by the reobstruction of the anastomotic tract by fibrotic scars and osteogenic activity. Fluoroscopically guided interventional procedures are a therapeutic alternative to surgery for lacrimal duct system obstructions that can consist either in balloon dacryocystoplasty or in nasolacrimal stent placement. In both cases, a pre-operative imaging characterization of the occlusion is needed for a correct treatment planning. In this review, we propose to highlight the role of interventional radiology in the treatment of epiphora and the role of computed tomography dacryocystography (CTD) in depiction and the pre-interventional planning.